Global Viral Infections Market clinical characteristics, landscape, approved treatments, late-stage pipeline 2021

Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Browse Complete Report with TOC @ http://bit.ly/2jlZA80

Scope

The viral infections market is large and growing rapidly

How do epidemiology trends differ among the key indications?
What therapeutic options exist for preventing and treating viral infections?
Which products and companies dominate the market?

The pipeline is innovative and diverse

What is the proportion of early- to late-stage pipeline products?
Which molecular targets are most prominent within the pipeline?
How do the key indications differ in terms of molecule type?

Considerable market growth is anticipated throughout 2021

Which products will contribute to this growth most significantly?
Will the current market leaders retain their dominance over the forecast period?

To Get Sample Copy of Report visit @ http://bit.ly/2knQRQz

Deal values for licensing and co-development deals range considerably

How many strategic consolidations have been completed in the past decade?
Which types of assets attract the largest deal values?

About Us:

MarketResearchStore.com is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.

Contact US:

Joel John
Suite #8138, 3422 SW 15 Street,
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803

This release was published on openPR.